Below are links to CECON pharmaceutical consultants with expertise in the development of regulatory strategies, regulatory submissions and interfacing with regulatory authorities. Experts can help prepare and submit FDA documents for investigatory new drugs (IND), new drug applications (NDA), or an abbreviated new drug applications (ANDA).